It’s been a busy week, with GPs slamming the pharmacy prescribing trial (again), vaccination and regulatory news, and some interesting financial results announced GPs are again complaining about the upcoming …

The number of Australians living with arthritis continues to grow, while medication myths and knowledge gaps can delay diagnosis and hinder treatment One in seven Australians live with arthritis. This …

The profession stands “ready and able”, say US pharmacists A group of 14 health organisations have written to the US health officials asking for all pharmacists in the country to …

A GP registrar has published Ahpra’s letter to him detailing his suspension, after he spread anti-vaccination misinformation and “aggressively” interrupted the AMA’s conference to broadcast it In July, Dr William …

Pharmacists can play an important role in helping people who are experiencing fatigue, writes Louis Roller “Fatigue is a symptom of something, it is not a disease.” – Health Direct …

In this podcast, pharmacists discuss a range of important topics including regulation, genomics, homeopathy and career barriers Our podcast host Carlene McMaugh has collated a series of interviews with leading …

UK to roll out NHS-funded pharmacist prescribers in community pharmacies, but on local soil, Australian doctors push back Pharmacist independent prescribing services will be trialled across England next year, reports …

Healthcare professionals urged to conserve tenecteplase (Metalyse) in wake of shortage due to surging global demand, to maintain continuity of supply for patients Boehringer Ingelheim Australia has advised the TGA …

Decrease in esomeprazole and increase in pantoprazole scripts likely due to restriction changes, says PBAC, though full picture obscured by lack of OTC and private data Restriction changes established in …

Health practitioners on the sub-register who are currently practising, can now extend their registration Ahpra has said that these practitioners may now opt in to extend their temporary registration, “so …

The number of Australians accessing cannabis legally via prescriptions has soared, new research shows – though many still obtain it illicitly to self-medicate New research from the University of Sydney’s …

PBAC recommends listing of adalimumab biosimilar The PBAC has recommended the Authority Required listing of adalimumab (Yuflyma) in the form of 40 mg in 0.4 mL pre-filled syringe and pre-filled …